Overview

MANP in Hypertension and Metabolic Syndrome

Status:
Completed
Trial end date:
2019-12-10
Target enrollment:
Participant gender:
Summary
Evaluate the cardiovascular and metabolic properties of MANP in subjects with HTN and MS according to rs5068 genotypes
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
American Heart Association